Many tumors display molecules like PD-L1 that tell immune cells to stop attacking. The area around a tumor can also be hostile, lacking oxygen or carrying suppressive signals such as FGFR4. Some treatments fail because highly active immune cells build up brakes like TIGIT, which can make them attack each other in a process called fratricide.